Danagreen

Provider of scaffolds to culture cells in 3D

placeSeoul, Seoul, South Korea calendar_todayFounded 2013 groups13 employees language danagreenbio.com

Innovation

10 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 135 times.

YearFilings
20191
20201
20214
20226
20232
20243

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital360%
Private equity120%
Bank & private debt120%
Coming soon